{"id":37615,"date":"2026-02-11T17:13:54","date_gmt":"2026-02-11T17:13:54","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/cancer-gene-therapy-market-mordor\/"},"modified":"2026-09-04T22:41:34","modified_gmt":"2026-09-04T13:41:34","slug":"cancer-gene-therapy-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/cancer-gene-therapy-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d \u2013 \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cancer-gene-therapy-market-1725280949098-Cancer-gene-therapy-logo.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cancer-gene-therapy-market-size-image-1768488680055.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 &amp; \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc554 \uc720\ubcd1\ub960 \ubc0f \uc778\uc2dd \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c FDA \uc2b9\uc778 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \uacf5\uacf5 \ubc0f \ubbfc\uac04 R&amp;D \uc790\uae08 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.4 \ud504\ub85c\uadf8\ub798\ubc0d \uac00\ub2a5\ud55c \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \uc804\ub2ec \ud601\uc2e0<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \ubca1\ud130 \uc124\uacc4\ub85c \uac1c\ubc1c \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc9c0\uc5ed\ubcc4 GMP \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uc81c\uc870 \ud5c8\ube0c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc554 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uaddc\uc81c \ubc0f \uc0c1\ud658 \ubd88\ud655\uc2e4\uc131<\/li>\n<li class=\"toc-level-3\">4.3.3 \uace0\ud615\uc554\uc5d0 \ub300\ud55c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0\uc758 \uc81c\ud55c\ub41c \ud655\uc7a5\uc131<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc885\uc591 \uc774\uc9c8\uc131\uc73c\ub85c \uc778\ud55c \ud615\uc9c8\ub3c4\uc785 \ud6a8\uc728 \uc800\ud558<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (USD \uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc \uc591\uc2dd\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc720\uc804\uc790 \uc720\ub3c4 \uba74\uc5ed\uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc720\uc804\uc790 \uc804\ub2ec \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.4 CRISPR \uae30\ubc18 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.5 RNAi \uae30\ubc18 \uc720\uc804\uc790 \uce68\ubb35 \uce58\ub8cc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ubca1\ud130 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130<\/li>\n<li class=\"toc-level-3\">5.2.2 \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc554 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ud608\uc561\uc554<\/li>\n<li class=\"toc-level-3\">5.3.2 \uace0\ud615\uc554<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \uc720\ubc29\uc554<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \ud3d0\uc554<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \uc804\ub9bd\uc120\uc554<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \ub300\uc7a5\uc554<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \ud751\uc0c9\uc885<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uae30\ud0c0 \uc554<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc554 \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud559\uc220 \ubc0f \uc815\ubd80 \uc5f0\uad6c\uc18c<\/li>\n<li class=\"toc-level-3\">5.4.3 \ubcd1\uc6d0 \ubc0f \uc554 \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc0dd\uba85\uacf5\ud559 \ubc0f \uc81c\uc57d \ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">5.4.5 \uc9c4\ub2e8 \uc5f0\uad6c\uc18c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.2 Gilead Sciences (Kite Pharma)<\/li>\n<li class=\"toc-level-3\">6.3.3 Bristol-Myers Squibb Company<\/li>\n<li class=\"toc-level-3\">6.3.4 Amgen Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 bluebird bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.6 Spark Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.7 Adaptimmune Therapeutics plc<\/li>\n<li class=\"toc-level-3\">6.3.8 Merck &amp; Co. Inc.<\/li>\n<li class=\"toc-level-3\">6.3.9 Ferring BV<\/li>\n<li class=\"toc-level-3\">6.3.10 Janssen Biotech Inc.<\/li>\n<li class=\"toc-level-3\">6.3.11 Celgene Corp.<\/li>\n<li class=\"toc-level-3\">6.3.12 Genexol Co. Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.13 Oncolytics Biotech Inc.<\/li>\n<li class=\"toc-level-3\">6.3.14 Cellectis SA<\/li>\n<li class=\"toc-level-3\">6.3.15 Ziopharm Oncology<\/li>\n<li class=\"toc-level-3\">6.3.16 Aveo Pharma<\/li>\n<li class=\"toc-level-3\">6.3.17 Sorrento Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.18 LogicBio Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.19 CG Oncology<\/li>\n<li class=\"toc-level-3\">6.3.20 Shanghai Cell Therapy Group<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5 \uac1c\uc694 (2026-2031\ub144 \uc131\uc7a5 \ucd94\uc138 \ubc0f \uc608\uce21)<\/p>\n<p>\uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc740 \uce58\ub8cc \uc591\uc2dd, \ubca1\ud130 \uc720\ud615, \uc554 \uc720\ud615, \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \uc788\uc73c\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc131\uc7a5 \ucd94\uc138\uc640 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ubd84\uc11d\ud569\ub2c8\ub2e4. Mordor Intelligence\uc758 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74, \uc774 \uc2dc\uc7a5\uc740 2025\ub144 249\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 671\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 17.92%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \ud68d\uae30\uc801\uc778 \uaddc\uc81c \uc2b9\uc778, \uc9c0\uc18d\uc801\uc778 \uc81c\uc870 \uaddc\ubaa8 \ud655\uc7a5, \uadf8\ub9ac\uace0 \uc2e4\ud5d8\uc2e4 \ud601\uc2e0\uc744 \uc77c\uc0c1\uc801\uc778 \uc885\uc591\ud559 \uc9c4\ub8cc\ub85c \uc804\ud658\uc2dc\ud0a4\ub294 \uc131\uc219\ud55c \uc804\ub2ec \uae30\uc220\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00, \uc815\ubc00 \uc758\ud559 \ud504\ub85c\uadf8\ub7a8\uc758 \uc2e0\uc18d\ud55c \ub3c4\uc785, \ud608\uc561\uc554 \ubc0f \uace0\ud615\uc554\uc744 \ubaa8\ub450 \ud45c\uc801\uc73c\ub85c \ud558\ub294 \ud6c4\uae30 \ub2e8\uacc4 \ud30c\uc774\ud504\ub77c\uc778\uc758 \ud655\uc7a5\uc73c\ub85c \uc778\ud574 \uac15\ub825\ud55c \uc218\uc694\uac00 \ubc1c\uc0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubca1\ud130 \ud50c\ub7ab\ud3fc\uc744 \ub458\ub7ec\uc2fc \uace0\uc561 \uc778\uc218 \ubc0f \uc804\ub7b5\uc801 \uc81c\ud734\ub97c \ud1b5\ud574 \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uace0 \uc788\uc73c\uba70, \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \uc99d\uac00\ub294 \uacf5\uae09 \uc81c\uc57d\uc744 \uc644\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc5ed\ub3d9\uc801\uc778 \uc694\uc18c\ub4e4\uc774 \uacb0\ud569\ub418\uc5b4 \uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \ud655\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ud5a5\ud6c4 \uba87 \ub144\uac04 \uc9c0\uc18d\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud2b9\ud788, \uc720\uc804\uc790 \ud3b8\uc9d1 \uae30\uc220\uc758 \ubc1c\uc804\uacfc \uc0c8\ub85c\uc6b4 \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ub354\uc6b1 \ubc15\ucc28\ub97c \uac00\ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc554 \uc720\uc804\uc790 \uce58\ub8cc\ub294 \ud658\uc790\uc758 \uc720\uc804\uc790\uc5d0 \uce58\ub8cc\uc6a9 DNA\ub97c \ub3c4\uc785\ud558\uc5ec \ub300\uc0ac\ub97c \uc870\uc808\ud558\uace0, \ud6c4\ucc9c\uc801 \uc720\uc804\uc801 \uc774\uc0c1\uc744 \ubcc0\uacbd \ub610\ub294 \ubcf5\uad6c\ud558\uba70, \uc138\ud3ec\uc5d0 \uc0c8\ub85c\uc6b4 \uae30\ub2a5\uc744 \ubd80\uc5ec\ud558\ub294 \ud601\uc2e0\uc801\uc778 \uc554 \uce58\ub8cc \uae30\uc220\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n2026\ub144 \uae30\uc900 \uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8\ub294 294\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud588\uc73c\uba70, 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 17.92%\uc758 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc554 \uc720\ubcd1\ub960 \ubc0f \uc778\uc2dd \uc99d\uac00, \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c FDA \uc2b9\uc778 \ud655\ub300, \uacf5\uacf5 \ubc0f \ubbfc\uac04 R&#038;D \uc790\uae08 \uc9c0\uc6d0 \uc99d\uac00, \ud504\ub85c\uadf8\ub798\ubc0d \uac00\ub2a5\ud55c \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP) \uc804\ub2ec \uae30\uc220\uc758 \ubc1c\uc804, AI \uae30\ubc18 \ubca1\ud130 \uc124\uacc4 \uac00\uc18d\ud654, \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4 GMP \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc81c\uc870 \ud5c8\ube0c \uad6c\ucd95 \ub4f1 \ub2e4\uc591\ud55c \uc694\uc778\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \uc554 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9, \uaddc\uc81c \ubc0f \ubcf4\ud5d8 \uc801\uc6a9\uc758 \ubd88\ud655\uc2e4\uc131, \uace0\ud615\uc554 \uce58\ub8cc\ub97c \uc704\ud55c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0\uc758 \uc81c\ud55c\uc801\uc778 \ud655\uc7a5\uc131, \uadf8\ub9ac\uace0 \uc885\uc591 \uc774\uc9c8\uc131\uc73c\ub85c \uc778\ud55c \ud615\uc9c8 \ub3c4\uc785 \ud6a8\uc728 \uc800\ud558 \ub4f1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \uac00\uaca9 \ubb38\uc81c\uc5d0 \ub300\uc751\ud558\uae30 \uc704\ud574 \uc9c0\ubd88\uc790 \ubc0f \uc81c\uc870\uc5c5\uccb4\ub294 \uac00\uce58 \uae30\ubc18 \uacc4\uc57d \ubc0f \ud560\ubd80 \uc9c0\ubd88 \ubaa8\ub378\uc744 \uc2dc\ubc94 \uc6b4\uc601\ud558\uc5ec \ube44\uc6a9 \ubd80\ub2f4\uc744 \ubd84\uc0b0\ud558\uace0 \uce58\ub8cc \uacb0\uacfc\uc640 \ubcf4\ud5d8 \uc801\uc6a9\uc744 \uc5f0\uacc4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \uc8fc\uc694 \ud2b8\ub80c\ub4dc:<br \/>\n\ubcf8 \uc2dc\uc7a5\uc740 \uce58\ub8cc \uc591\uc2dd, \ubca1\ud130 \uc720\ud615, \uc554 \uc720\ud615, \ucd5c\uc885 \uc0ac\uc6a9\uc790, \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc591\uc2dd\ubcc4: \uc720\uc804\uc790 \uc720\ub3c4 \uba74\uc5ed\uce58\ub8cc, \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uce58\ub8cc, \uc720\uc804\uc790 \uc804\ub2ec \uce58\ub8cc, CRISPR \uae30\ubc18 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc, RNAi \uae30\ubc18 \uc720\uc804\uc790 \uce68\ubb35 \uce58\ub8cc \ub4f1\uc73c\ub85c \ub098\ub269\ub2c8\ub2e4. \uc774 \uc911 \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uce58\ub8cc(Oncolytic Virotherapy)\uac00 \ud655\ub9bd\ub41c \uc784\uc0c1 \uc0ac\uc6a9 \ubc0f \uaddc\uc81c \uce5c\uc219\uc131\uc744 \ubc14\ud0d5\uc73c\ub85c 43.02%\uc758 \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubca1\ud130 \uc720\ud615\ubcc4: \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\uc640 \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4.<br \/>\n*   \uc554 \uc720\ud615\ubcc4: \ud608\uc561\uc554\uacfc \uace0\ud615\uc554(\uc720\ubc29\uc554, \ud3d0\uc554, \uc804\ub9bd\uc120\uc554, \ub300\uc7a5\uc554, \ud751\uc0c9\uc885 \ubc0f \uae30\ud0c0 \uc554 \ud3ec\ud568)\uc73c\ub85c \ubd84\ub958\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc554 \uc5f0\uad6c \uae30\uad00, \ud559\uc220 \ubc0f \uc815\ubd80 \uc5f0\uad6c\uc18c, \ubcd1\uc6d0 \ubc0f \uc554 \uc13c\ud130, \uc0dd\uba85\uacf5\ud559 \ubc0f \uc81c\uc57d \ud68c\uc0ac, \uc9c4\ub2e8 \uc5f0\uad6c\uc18c \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ub4f1), \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d \ub4f1), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub85c \uad6c\uc131\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc911\uad6d\uc758 \uc81c\uc870 \uae30\ubc18\uacfc \uc2e0\uc18d\ud55c \uaddc\uc81c \uacbd\ub85c\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 29.82%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae30\uc220\uc801 \ud601\uc2e0:<br \/>\nCRISPR \uae30\ubc18 \uc720\uc804\uc790 \ud3b8\uc9d1 \ud50c\ub7ab\ud3fc\uc740 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP) \uc804\ub2ec \uae30\uc220\uacfc \uacb0\ud569\ud558\uc5ec \ud608\uc561\uc554 \ubc0f \uace0\ud615\uc554 \uce58\ub8cc \ud30c\uc774\ud504\ub77c\uc778\uc744 \uc7ac\ud3b8\ud558\ub294 \uac00\uc7a5 \ud30c\uad34\uc801\uc778 \uae30\uc220 \ud2b8\ub80c\ub4dc\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. AI \uae30\ubc18 \ubca1\ud130 \uc124\uacc4 \ub610\ud55c \uac1c\ubc1c \uc18d\ub3c4\ub97c \uac00\uc18d\ud654\ud558\ub294 \uc911\uc694\ud55c \uc694\uc18c\uc785\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<br \/>\n\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Novartis AG, Gilead Sciences (Kite Pharma), Bristol-Myers Squibb Company, Amgen Inc., bluebird bio Inc., Spark Therapeutics Inc. \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \uac01 \uae30\uc5c5 \ud504\ub85c\ud544\uc5d0\ub294 \uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ucda9\uc871 \uc218\uc694\uc5d0 \ub300\ud55c \ud3c9\uac00\ub97c \uc81c\uacf5\ud558\uba70, \uc554 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc758 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-37615","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/37615"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=37615"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/37615\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=37615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=37615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=37615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}